This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shortland, D. B Articles by Dey Chowdhury, A. Search for Related Content Social Bookmarking                         What's this?

Understanding neonatal jaundice: UK practice and international profile

Department of Paediatrics and Child Health, Poole Hospital NHS Trust, Longfleet Road, Poole, Dorset BH15 2JB, david.shortland{at}poole.nhs.uk

Martin Hussey

Department of Paediatrics and Child Health, Poole Hospital NHS Trust, Longfleet Road, Poole, Dorset BH15 2JB

Ashoka Dey Chowdhury

Department of Paediatrics and Child Health, Poole Hospital NHS Trust, Longfleet Road, Poole, Dorset BH15 2JB

Over the last 25 years there have been considerable advances in the treatment and technologies used in the care of newborn infants. Most of these advances are related to the care of the premature infants and there have been few changes in the management of conditions commonly seen in term infants.

Neonatal jaundice is one of the commonest neonatal disorders and has been recognized since early history. Early neonatal jaundice is usually caused by the physiological destruction of red blood cells in the infant and its importance lies in the ability of the bilirubin pigment so produced to cross the blood brain barrier resulting in neurotoxicity. Prolonged neonatal jaundice (after 14 days of age) may be an indication of an underlying liver disorder. The approach to neonatal jaundice has remained largely unchanged over the last two to three decades. We continue to rely on visual inspection to assess the severity of early neonatal jaundice. We have technology that is effective in reducing the level of bilirubinaemia but in the UK there is no clear consensus as to the level at which jaundice should be treated. We do not have a standardized approach to the management of prolonged jaundice and there is potential for infants with significant liver problems to be diagnosed at a relatively late stage. Some countries (for example the US) have professional bodies who have introduced guidelines to ensure a standardized approach to the jaundice infant. We have little information about neonatal jaundice treatment in other parts of the developing world.

Key Words: Neonatal jaundice • aetiology • recognition • management

The Journal of the Royal Society for the Promotion of Health, Vol. 128, No. 4, 202-206 (2008)
DOI: 10.1177/1466424008092229


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?